by Roman Bystrianyk
Monday, 21 September 2009 22:17
http://www.healthsentinel.com/joomla/index.php?option=com_content&view=article&id=2598:study-clearly-demonstrates-that-aluminum-found-in-vaccines-can-cause-neurologic-damage&catid=5:original&Itemid=24
Randi Allaire was an Information Management Specialist in the military for
almost four years. Three and one-half years were spent with the Air National
Guard as Information Management, the previous five and half was with the Army
Guard as a Flight Operations Specialist.
As part of the military's program to protect their troops from chemical and
biological weapons, Randi was required to take the anthrax vaccine. On March 14,
1999 she was given her fourth anthrax vaccine. It was after that shot that she
has suffered chronic fatigue, memory lapses, migraines, pain in the forearms,
and other aches and pains. She received no help with her condition and only
denials that the anthrax vaccine could cause any of these problems and that the
cause of her problems was likely the "flu" or too much "stress". She was
eventually thrown out of the military because she refused to take the fifth
anthrax vaccine shot in fear for her own personal health.
Aluminum is the most commonly licensed adjuvant that is added to a large number
of vaccines. An adjuvant is a substance added to a vaccine to amplify the immune
response. Aluminum compounds, which were identified over 90 years ago as
adjuvants, are considered by the pharmaceutical industry and various government
agencies as safe. The FDA (Food and Drug Administration) has continued to
approve the use of aluminum as an additive to vaccines for many years.
Despite these assurances that aluminum and all vaccine ingredients are safe,
large numbers of military veterans who suffer from Gulf War Syndrome as well as
parents of children who suffer from various neurologic conditions including
Autism strongly believe that the vaccines were often at least in part a cause of
their health problems.
A recent study in the Journal of Inorganic Biochemistry examined
the possible neurotoxicity of aluminum. This new work builds on a previous study
where the researchers had injected mice with a combination of aluminum and
squalene, another vaccine adjuvant which is not licensed in North America.
In that study the investigators injected mice with adjuvants that mimicked the
anthrax vaccine schedule set by the Anthrax Vaccine Immunization Program. The
investigators concluded in that study"our data suggest that the aluminum
hydroxide adjuvant induces both behavioral and motor deficits and the loss of
motor neurons and increased presence of astrocytes [astrocytes are cells that
express inflammatory markers] in spinal cord and neuronal apoptosis [cell death]
in the primary motor cortex." When Professor Shaw was asked in an article by
Pieta Wooley about this research Professor Shaw replied "No one in my lab wants
to get vaccinated. This totally creeped us out. We weren't out there to poke
holes in vaccines. But all of a sudden, oh my God-we've got neuron death!"
In this new study (also termed experiment 2), mice received 6 aluminum hydroxide
injections over a 2 week period. These mice along with control mice were
subjected to a more rigorous behavioral testing regime than the original
experiment.
The investigators found "the multiple aluminum hydroxide injections of
experiment 2 showed profound effects on motor and other behaviours... Multiple
aluminum injections produced significant behavioural outcomes including changes
in locomotion behavior, and induced memory deficits on water maze tasks."
I asked Professor Shaw "To your knowledge have there been any autopsies
performed on service men and women that had GWS [Gulf War Syndrome] and have
died to examine if they have a similar pattern of aluminum contamination that
you discovered in your research?" He responded "that it has not been done to my
knowledge." I also asked "Has there been an examination of people with autism to
examine the obvious likely link between aluminum and mercury contamination and
that condition?" Again he responded "Not to my knowledge."
It is important to note that while this and their previous study showed
"significant behavioural and neuropathological outcomes with aluminum hydroxide"
that these results were achieved under minimal conditions and that the effect of
multiple other factors in real situation such as "stress, multiple vaccinations,
and exposure to other toxins" would more than likely make the outcomes worse. "A
recent study examining some of these factors in combination showed that stress,
vaccination, and pyridostigmine bromide (Pyridostigmine bromide has been FDA
approved for military use during combat situations as an agent to be given prior
to exposure to the nerve agent Soman in order to increase survival), may
synergistically act on multiple stress-activated kinases in the brain to induce
neurologic impairment in GWS."
I asked Professor Shaw, "In your opinion why do various governmental agencies
continue to insist that vaccines are safe when you clearly state in your
research paper that ‘it also seems that there have been no rigorous animal
studies of potential aluminum adjuvant toxicity. The absence of such studies is
peculiar given the well known observation that aluminum in general can be
neurotoxic under a number of conditions and adjuvants in particular have
previously been implicated in neurological disease'?" Professor Shaw replied "A
less charitable person than I would likely look at links between pharma and the
regulatory agencies. I don't know of any safe adjuvants. Aluminum is the one
considered ‘safe'."
The authors conclude, "Overall, the results reported here mirror previous work
that has clearly demonstrated that aluminum, in both oral and injected forms,
can be neurotoxic." I followed up with Professor Shaw "knowing what you know
about aluminum from your research would you personally use a vaccine that
contains aluminum?" He responded "No, and I don't."
The following vaccines (vaccine name/trade name, manufacturer, and information
from the product insert) contain aluminum adjuvant:
Anthrax Vaccine Adsorbed/Biothrax, Emergent BioDefense Operations
Lansing, Inc., "The final product is formulated to contain 1.2 mg/mL aluminum,
added as aluminum hydroxide in 0.85% sodium chloride."
Diphtheria & Tetanus Toxoids Adsorbed, Sanofi Pasteur Inc, "Each 0.5 mL
dose is formulated to contain 6.7 Lf of diphtheria toxoid, 5 Lf of tetanus
toxoid, and not more than 0.17 mg of aluminum."
Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed/Tripedia,
Sanofi Pasteur, Inc., "Each 0.5 mL dose also contains, by assay, not more than
0.170 mg of aluminum and not more than 100 g (0.02%) of residual formaldehyde."
Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed/Infanrix,
GlaxoSmithKline Biologicals, "Each 0.5-mL dose contains 4.5 mg of NaCl and
aluminum adjuvant (not more than 0.625 mg aluminum by assay). Each dose also
contains 100 mcg of residual formaldehyde and 100 mcg of polysorbate 80 (Tween
80)."
Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed/DAPTACEL,
Sanofi Pasteur, Ltd., "Other ingredients per 0.5 mL dose include 1.5 mg aluminum
phosphate (0.33 mg of aluminum) as the adjuvant, 5 g residual formaldehyde, <50
ng residual glutaraldehyde and 3.3 mg (0.6% v/v) 2-phenoxyethanol (not as a
preservative)."
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B
(Recombinant) and Inactivated Poliovirus Vaccine Combined/Pediarix,
GlaxoSmithKline Biologicals, "Each 0.5-mL dose also contains 4.5 mg of NaCl and
aluminum adjuvant (not more than 0.85 mg aluminum by assay). Each dose also
contains 100 mcg of residual formaldehyde and 100 mcg of polysorbate 80 (Tween
80)."
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and
Inactivated Poliovirus Vaccine/Kinrix, GlaxoSmithKline Biologicals, "Each
0.5-mL dose contains 4.5 mg of NaCl and aluminum adjuvant (not more than 210 0.6
mg aluminum by assay). Each dose also contains 100 mcg of residual formaldehyde
and 211 100 mcg of polysorbate 80 (Tween 80)."
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated
Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate)
Vaccine/Pentacel, Sanofi Pasteur, Ltd, "Other ingredients per 0.5 mL dose
include 1.5 mg aluminum phosphate (0.33 mg aluminum) as the adjuvant,
polysorbate 80 (approximately 10 ppm by calculation), 5 g residual formaldehyde,
<50 ng residual glutaraldehyde, 50 ng residual bovine serum albumin, 3.3 mg
(0.6% v/v) 2-phenoxyethanol (not as a preservative) and <4 pg of neomycin and <4
pg polymyxin B sulfate. "
Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B
(Recombinant) Vaccine/Comvax, Merck & Co, Inc, "The individual PRP-OMPC and
HBsAg adjuvanted bulks are combined to produce COMVAX. Each 0.5 mL dose of
COMVAX is formulated to contain 7.5 mcg PRP conjugated to approximately 125 mcg
OMPC, 5 mcg HBsAg, approximately 225 mcg aluminum as amorphous aluminum
hydroxyphosphate sulfate, and 35 mcg sodium borate (decahydrate) as a pH
stabilizer, in 0.9% sodium chloride. The vaccine contains not more than 0.0004%
(w/v) residual formaldehyde."
Hepatitis A Vaccine, Inactivated/Havrix, GlaxoSmithKline Biologicals,
"Each 1-mL adult dose of vaccine consists of 1440 EL.U. of viral antigen,
adsorbed on 0.5 mg of aluminum as aluminum hydroxide. Each 0.5-mL pediatric dose
of vaccine consists of 720 EL.U. of viral antigen, adsorbed onto 0.25 mg of
aluminum as aluminum hydroxide."
Hepatitis A Vaccine, Inactivated/VAQTA, Merck & Co, Inc, "Pediatric/Adolescent
Formulation (12 Months Through 18 Years of Age): each 0.5 mL dose contains
approximately 25U of hepatitis A virus antigen adsorbed onto approximately 0.225
mg of aluminum provided as amorphous aluminum hydroxyphosphate sulfate, and 35
mcg of sodium borate as a pH stabilizer, in 0.9% sodium chloride. Adult
Formulation (19 Years of Age and Older): each 1 mL dose contains approximately
50U of hepatitis A virus antigen adsorbed onto approximately 0.45 mg of aluminum
provided as amorphous aluminum hydroxyphosphate sulfate, and 70 mcg of sodium
borate as a pH stabilizer, in 0.9% sodium chloride."
Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine/Twinrix,
GlaxoSmithKline Biologicals, "A 1.0-mL dose of vaccine contains 720 ELISA Units
of inactivated hepatitis A virus and 20 mcg of recombinant HBsAg protein. One
dose of vaccine also contains 0.45 mg of aluminum in the form of aluminum
phosphate and aluminum hydroxide as adjuvants, amino acids, 5.0 mg
2-phenoxyethanol as a preservative, sodium chloride, phosphate buffer,
polysorbate 20, Water for Injection, traces of formalin (not more than 0.1 mg),
a trace amount of thimerosal (<1 mcg mercury) from the manufacturing process,
and residual MRC-5 cellular proteins (not more than 2.5 mcg)."
Hepatitis B Vaccine (Recombinant)/Engerix-B, GlaxoSmithKline Biologicals,
"Pediatric/Adolescent: Each 0.5-mL dose contains 10 mcg of hepatitis B surface
antigen adsorbed on 0.25 mg aluminum as aluminum hydroxide. The pediatric
formulation contains sodium chloride (9 mg/mL) and phosphate buffers (disodium
phosphate dihydrate, 0.98 mg/mL; sodium dihydrogen phosphate dihydrate, 0.71 mg/mL).
Adult: Each 1-mL adult dose contains 20 mcg of hepatitis B surface antigen
adsorbed on 0.5 mg aluminum as aluminum hydroxide. The adult formulation
contains sodium chloride (9 mg/mL) and phosphate buffers (disodium phosphate
dihydrate, 0.98 mg/mL; sodium dihydrogen phosphate dihydrate, 0.71 mg/mL)."
Hepatitis B Vaccine (Recombinant)/Recombivax HB, Merck & Co, Inc, "All
formulations contain approximately 0.5 mg of aluminum (provided as amorphous
aluminum hydroxyphosphate sulfate, previously referred to as aluminum hydroxide)
per mL of vaccine. In each formulation, hepatitis B surface antigen is adsorbed
onto approximately 0.5 mg of aluminum (provided as amorphous aluminum
hydroxyphosphate sulfate) per mL of vaccine."
Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine,
Recombinant/Gardasil, Merck & Co, Inc, "Each 0.5-mL dose of the vaccine
contains approximately 225 mcg of aluminum (as Amorphous Aluminum
Hydroxyphosphate Sulfate adjuvant), 9.56 mg of sodium chloride, 0.78 mg of L-histidine,
50 mcg of polysorbate 80, 35 mcg of sodium borate, < 7 mcg yeast protein/dose,
and water for injection. The product does not contain a preservative or
antibiotics."
Japanese Encephalitis Vaccine, Inactivated, Adsorbed (Military & Commercial)/Ixiaro,
Merck & Co, Inc, "Each dose of vaccine contains approximately 6 mcg of purified,
inactivated JEV proteins and 250 mcg of aluminum hydroxide."
Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)/Prevnar,
Wyeth Pharmaceuticals, Inc, "Each 0.5 mL dose is formulated to contain: 2 g of
each saccharide for serotypes 4, 9V, 14, 18C, 19F, and 23F, and 4 g of serotype
6B per dose (16 g total saccharide); approximately 20 g of CRM197 carrier
protein; and 0.125 mg of aluminum per 0.5 mL dose as aluminum phosphate
adjuvant."
Tetanus & Diphtheria Toxoids, Adsorbed for Adult Use, Massachusetts
Public Health Biologic Lab, "Each 0.5 ml dose contains by calculation not more
than 0.45 mg aluminum and less than 100 g (0.02%) of residual formaldehyde. The
aluminum phosphate functions as an adjuvant to increase the immunogenicity of
the toxoids in primary immunization."
Tetanus & Diphtheria Toxoids Adsorbed for Adult Use/DECAVAC, Sanofi
Pasteur, Inc, "Each 0.5 mL dose also contains a trace amount of thimerosal
[mercury derivative, ( 0.3 g mercury/dose) not as a preservative] from the
manufacturing process, aluminum adjuvant (not more than 0.28 mg aluminum by
assay), and not more than 100 g (0.02%) of residual formaldehyde."
Tetanus Toxoid Adsorbed, Sanofi Pasteur, Inc, "Each 0.5 mL dose is
formulated to contain 5 Lf (flocculation units) of tetanus toxoid and not more
than 0.25 mg of aluminum. The residual formaldehyde content, by assay, is less
than 0.02%."
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine,
Adsorbed/Adacel, Sanofi Pasteur, Ltd, "Other ingredients per dose include
1.5 mg aluminum phosphate (0.33 mg aluminum) as the 15 adjuvant, 5 g residual
formaldehyde, <50 ng residual glutaraldehyde and 3.3 mg (0.6% v/v) 16
2-phenoxyethanol (not as a preservative)."
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine,
Adsorbed/ Boostrix, GlaxoSmithKline Biologicals, "Each 0.5-mL dose also
contains 4.5 mg of NaCl, aluminum adjuvant (not more than 0.39 mg aluminum by
assay), 100 mcg of residual formaldehyde, and 100 mcg of polysorbate 80 (Tween
80)."